239 related articles for article (PubMed ID: 18342917)
1. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
3. The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting.
Kastner C; Armitage J; Kimble A; Rawal J; Carter PG; Venn S
Prostate Cancer Prostatic Dis; 2006; 9(3):270-4. PubMed ID: 16770340
[TBL] [Abstract][Full Text] [Related]
4. Is there an optimal comorbidity index for prostate cancer?
Alibhai SM; Leach M; Tomlinson GA; Krahn MD; Fleshner NE; Naglie G
Cancer; 2008 Mar; 112(5):1043-50. PubMed ID: 18286512
[TBL] [Abstract][Full Text] [Related]
5. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
[TBL] [Abstract][Full Text] [Related]
6. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004.
Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M;
Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222
[TBL] [Abstract][Full Text] [Related]
7. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.
Murray SB; Bates DW; Ngo L; Ufberg JW; Shapiro NI
Acad Emerg Med; 2006 May; 13(5):530-6. PubMed ID: 16551775
[TBL] [Abstract][Full Text] [Related]
8. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
Adolfsson J; Tribukait B; Levitt S
Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
[TBL] [Abstract][Full Text] [Related]
9. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study.
Lund L; Jacobsen J; Clark P; Borre M; Nørgaard M;
Urology; 2010 Feb; 75(2):393-8. PubMed ID: 19914698
[TBL] [Abstract][Full Text] [Related]
10. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
[TBL] [Abstract][Full Text] [Related]
11. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
[TBL] [Abstract][Full Text] [Related]
13. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.
Hall WH; Jani AB; Ryu JK; Narayan S; Vijayakumar S
Prostate Cancer Prostatic Dis; 2005; 8(1):22-30. PubMed ID: 15700051
[TBL] [Abstract][Full Text] [Related]
14. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery.
Nuttall M; van der Meulen J; Emberton M
J Clin Epidemiol; 2006 Mar; 59(3):265-73. PubMed ID: 16488357
[TBL] [Abstract][Full Text] [Related]
15. The impact of comorbidity and age on survival with laryngeal cancer.
Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
[TBL] [Abstract][Full Text] [Related]
16. Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007).
Nørgaard M; Jensen AØ; Jacobsen JB; Cetin K; Fryzek JP; Sørensen HT
J Urol; 2010 Jul; 184(1):162-7. PubMed ID: 20483155
[TBL] [Abstract][Full Text] [Related]
17. Differential prognostic impact of comorbidity.
Read WL; Tierney RM; Page NC; Costas I; Govindan R; Spitznagel EL; Piccirillo JF
J Clin Oncol; 2004 Aug; 22(15):3099-103. PubMed ID: 15284260
[TBL] [Abstract][Full Text] [Related]
18. Predictive validity of five comorbidity indices in prostate carcinoma patients treated with curative intent.
Boulos DL; Groome PA; Brundage MD; Siemens DR; Mackillop WJ; Heaton JP; Schulze KM; Rohland SL
Cancer; 2006 Apr; 106(8):1804-14. PubMed ID: 16534794
[TBL] [Abstract][Full Text] [Related]
19. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
Fisher DA; Galanko J; Dudley TK; Shaheen NJ
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
[TBL] [Abstract][Full Text] [Related]
20. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]